Streetbeat News

Stock Prices

CVS

ET

HD

PLTR

PYPL

RIVN

Jim Cramer recommends buying PayPal due to its expanded partnership with Shopify. He advises patience with Rivian, despite its financial stability. Cramer is cautious about CVS Health and sees potential in Energy Transfer and The Home Depot. Palantir is noted for its S&P 500 inclusion.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 12:41 pm

QSR

Restaurant Brands International Inc. (RBI) has announced the renewal of its normal course issuer bid, allowing the company to repurchase up to $500 million of its common shares by September 30, 2025. This move is part of RBI's capital allocation strategy, although the company is currently prioritizing its 2024 net leverage target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:40 pm

GLXG

Galaxy Payroll has announced the pricing of its initial public offering (IPO) at $4.00 per share, aiming to raise $7 million by offering 1.75 million shares. This move marks Galaxy Payroll's entry into the public market.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:39 pm

LFWD

ReWalk Robotics Ltd. has officially changed its corporate name to Lifeward Ltd. following shareholder and regulatory approvals. The company, listed on NASDAQ under the symbol LFWD, aims to enhance its brand identity in the rehabilitation and recovery sector.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:39 pm

GILD

Gilead Sciences' shares rose following positive interim results from a Phase 3 trial of Lenacapavir, which showed a 96% reduction in HIV infections with twice-yearly administration.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:38 pm

FTXO

IAT

USB

U.S. Bancorp has announced a new $5 billion share repurchase program and a 2% increase in its quarterly dividend to 50 cents per share. The buyback will start in early 2025, and the dividend will be paid on October 15. USB shares are trading higher in premarket.

Portfolio Pulse from Nabaparna Bhattacharya

September 12, 2024 | 12:38 pm

GILD

Gilead Sciences announced positive interim results from a second Phase 3 trial of its drug Lenacapavir, which showed a 96% reduction in HIV infections with twice-yearly administration.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:36 pm

TEM

Tempus AI, Inc. (NASDAQ:TEM) has launched the beta version of 'olivia', an AI-enabled personal health concierge app. The app aims to help patients manage their health data more effectively by aggregating information, tracking symptoms, and preparing for medical appointments.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:36 pm

KUKE

KUKE Music Holding Limited has regained compliance with the New York Stock Exchange's (NYSE) listing standards. This development follows the company's efforts to meet the minimum share price requirement, ensuring its continued presence on the exchange.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:35 pm

SIG

Signet Jewelers reported a mixed Q2 2025 earnings with a sales decline but an EPS beat. The company is net debt positive and has a strong Q3 outlook, leading to a 12.7% premarket stock increase.

Portfolio Pulse from Anusuya Lahiri

September 12, 2024 | 12:34 pm